David Miller, MD, PhD, FAAD
SESSIONS
F068 What's New in the Management of Advanced Skin Cancer
Mar 9, 2025
•
3:30 PM - 5:30 PM
•
W307A
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Avstera Therapeutics Corp – Advisory Board(Stock Options); Bristol Myers Squibb – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Fees); Checkpoint Therapeutics – Advisory Board(Honoraria), Advisory Board(Stock Options); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);